Catalyst Wire Dossier Catalyst Wire Dossier

Reduced-antigen-content acellular pertussis vaccine

reduced-antigen-content acellular pertussis vaccine · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Reduced-antigen-content acellular pertussis vaccine, covering 2010-12-17 to 2010-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine [Phase 3]

See pricing